Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Liabilities from Discontinued Operations (2024)

Roivant Sciences (ROIV) has disclosed Liabilities from Discontinued Operations for 1 consecutive years, with 110405000.0 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Liabilities from Discontinued Operations changed N/A year-over-year to 110405000.0, compared with a TTM value of 110405000.0 through Mar 2024, changed N/A, and an annual FY2024 reading of 110405000.0, changed N/A over the prior year.
  • Liabilities from Discontinued Operations was 110405000.0 for Q1 2024 at Roivant Sciences.
  • Across five years, Liabilities from Discontinued Operations topped out at 110405000.0 in Q1 2024 and bottomed at 110405000.0 in Q1 2024.